How is Venofer (iron sucrose) mixed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Mix Venofer (Iron Sucrose)

Venofer (iron sucrose) can be administered either as a slow intravenous injection or as an infusion, with specific mixing instructions depending on the administration method and dose.

Preparation Options

  • Venofer contains 20 mg of elemental iron per ml and is available in 100 mg (5 ml) vials 1

  • For direct IV injection (slow IV push):

    • Can be administered undiluted at a rate of 100 mg over 2-5 minutes (FDA guidelines) 1
    • No dilution required for this method of administration 2
  • For IV infusion:

    • Dilute in normal saline solution 1
    • Administer over 15 minutes (FDA guidelines) for doses up to 200 mg 1
    • Administer over 30 minutes (European Medicines Agency guidelines) for doses up to 200 mg 1

Dosing Considerations

  • Maximum single dose: 200 mg 1
  • Maximum weekly dose: 500 mg 1
  • Typical administration is 100 mg per dose, which minimizes risk of arthralgia-myalgia reactions 1
  • No test dose is required before administration (unlike iron dextran) 3, 2

Administration Precautions

  • Monitor vital signs during and after infusion 4
  • Resuscitation facilities should be available during administration due to potential for hypersensitivity reactions 4
  • Bolus intravenous dosing of iron sucrose (200 mg iron) over 10 minutes is licensed and more convenient than a 2-hour infusion 4
  • Free iron may occur if 100 mg is administered when transferrin levels are less than 180 mg/dL 1

Potential Adverse Effects to Monitor

  • Hypotension and flushing (rare) 1, 5
  • Abdominal cramps (rare, particularly when co-administered with ACE inhibitors) 1, 5
  • Arthralgias and myalgias (acute rather than delayed) 1, 5
  • These adverse effects are dose-related and rarely occur with doses of 100 mg or less 1

Clinical Efficacy Monitoring

  • Transferrin and ferritin levels can be measured reliably 48 hours after IV administration 3
  • Follow hemoglobin, ferritin, and transferrin saturation levels to assess response to therapy 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Research

Iron sucrose: the oldest iron therapy becomes new.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002

Guideline

Administration of Iron Sucrose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dark-Colored Urine Following Iron Sucrose Infusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.